Post-refractive IOL Outcomes With Clareon TruPlus

This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.

NCT Number	NCT07610226
Lead Sponsor	Laser Defined Vision Collaborators: Sengi
Conditions	Cataract
Enrollment	35 participants
Start Date	2026-06-25
Primary Completion	2027-06-23 (estimated)
Study Completion	2027-06-23 (estimated)
Updated on ClinicalTrials.gov	2026-07-23